Lawrence E. Bullock, Chief Financial Officer at BIOMIMETIC THERAPEUTICS, INC. (BMTI), bought 20,000 shares at $2.20 ($44K) on 2012-03-19, disclosed to the SEC on 2012-03-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.20 | 2,330 | $5K | 11.7% |
| 2 | $2.20 | 17,670 | $39K | 88.3% |
| Total | $2.20 avg | 20,000 | $44K | 100% |
| Filing → |
| BMTI | BUY | 2008-04-01 | $90K | — | Filing → |
| BMTI | BUY | 2006-05-15 | $80K | — | Filing → |